Virus-specific cluster of differentiation 8 (CD8+) cytotoxic T cells (CTL) recognize viral
antigens presented on major histocompatibility complex (MHC) class I chains on infected …

Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes
and life-threatening consequences for patients, in spite of modern vaccination and antiviral …

Chronic hepatitis B (CHB) remains a global healthcare burden. Although the recent
developments in the field have led to a reduction in incidence, the morbidity and mortality …

Background This study aimed to investigate the level of awareness of and factors associated
with major infectious diseases in rural China and to provide the most recent baseline data …

Complete eradication of hepatitis B virus (HBV) is rarely achieved. Treatment options
include currently available nucleos (t) ide analogues and pegylated interferon. The aim of …

Background Hepatitis B Virus (HBV) can affect life quality. Monitoring and understanding the
fluctuations of the HBV level of viremia related to the intricate immune activity of the host …

Abstract According to the World Health Organization (WHO) report, viral hepatitis has been a
problem in human society. Vitamins play a significant role in preventing the …

Immune stimulating complexes (ISCOMs) incorporating recombinant hepatitis B surface
antigen (HBsAg) was prepared for induction of humoral, cellular and mucosal immunity by …

During the course of human immunodeficiency virus type 1 (HIV-1) disease, the virus has
been shown to effectively escape the immune response with the subsequent establishment …

Objectives 10 hepatitis B virus (HBV) genotypes are known with different geographic
distribution and response to interferon (IFN) therapy. The E genotype is the more prevalent …